Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
EUDA Health Holdings ( (EUDA) ) has shared an update.
On October 23, 2025, EUDA Health Holdings Limited announced that its subsidiary, CK Health Plus, will expand into the Indian market through a strategic partnership with SafeRock India. This collaboration aims to leverage SafeRock India’s extensive network to introduce CK Health Plus’ Bioenergy Capsule Therapies and supplements across major Indian cities, building a sustainable wellness ecosystem. This move positions EUDA to capitalize on India’s growing wellness and preventive healthcare market, driven by a burgeoning middle class and increased focus on long-term health.
The most recent analyst rating on (EUDA) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on EUDA Health Holdings stock, see the EUDA Stock Forecast page.
More about EUDA Health Holdings
EUDA Health Holdings Limited is a Singapore-based leading non-invasive healthcare provider in Asia, focusing on Singapore, Malaysia, and China. The company aims to become a market leader in non-invasive and preventive healthcare, particularly in the fast-growing longevity sector, addressing the evolving healthcare needs of over 1.8 billion people in the region. EUDA also operates a property management business in Singapore.
Average Trading Volume: 116,435
Technical Sentiment Signal: Hold
Current Market Cap: $117.4M
See more data about EUDA stock on TipRanks’ Stock Analysis page.